Avion Wealth’s NRX Pharmaceuticals NRXP Stock Holding History

Avion Wealth’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Hold	294	–	–	﹤0.01%	1293
2026 Q1	$0	Buy	+294	New	+$593	﹤0.01%	1486

Other funds holding NRXP

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Avion Wealth's NRXP Position: Q2 2026 in Review

Avion Wealth held its NRX Pharmaceuticals (NRXP) position steady in Q2 2026 at 294 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1293.

Avion Wealth first reported a position in NRXP in Q1 2026 and has held it in 2 quarters since. 47 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

Avion Wealth held 294 shares of NRX Pharmaceuticals worth $1K as of Q2 2026.
Avion Wealth left its NRX Pharmaceuticals share count unchanged in Q2 2026.
NRX Pharmaceuticals made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1293 holding.
Avion Wealth first reported a position in NRX Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
47 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.